Smoking Ups Risk of Complications From Urologic Cancers: Study

Smoking Ups Risk of Complications From Urologic Cancers: Study

Smoking Ups Risk of Complications From Urologic Cancers: Study

Although former smokers also have higher odds of trouble, quitting does help

SOURCE: Henry Ford Health System, news release, May 15, 2015

FRIDAY, May 15, 2015 (HealthDay News) -- Current and former smokers have more complications from major surgery for some urology-related cancers, according to new research.

But even though former smokers have a higher risk of complications than non-smokers, the study also found that quitting smoking for as little as a year before surgery could "significantly" improve the outcomes of surgery.

"These findings should provide motivation for all patients to quit smoking before undergoing major surgery. It's clear that they can expect better results with fewer complications if they do," Dr. Akshay Sood, a urologist and researcher at Henry Ford Hospital's Vattikuti Urology Institute, said in a hospital news release.

The researchers focused on just over 9,000 patients who underwent surgery for cancers of the prostate, bladder or kidney from 2005 to 2011.

They found that smokers were more likely to suffer from lung and kidney complications after prostate surgery. Smokers were also more likely to spend a longer time in the hospital after prostate surgery.

Smoking didn't seem to boost the risk of complications from bladder or kidney cancer surgery. Still, bladder cancer patients who currently smoked were more likely to need an additional surgery. And those who previously smoked had a higher risk of returning to the hospital. Prostate cancer patients, meanwhile, appeared to benefit if they quit smoking as little as a year before surgery.

"Besides demonstrating negative effects of smoking on surgical outcomes, our research found that those effects differed according to the procedure performed," Sood noted.

Findings from the study are scheduled to be presented May 15 at the American Urological Association meeting in New Orleans. Data and conclusions presented at meetings are usually viewed as preliminary until published in a peer-reviewed journal.

More information

For more about urologic cancer, try the University of California, San Francisco.
Copyright © 2015 HealthDay. All rights reserved.